Home・Stock List・Actinium Pharmaceuticals Inc

Actinium Pharmaceuticals Inc

Closed

1.03 8.42

Buy Sell

Overview

Share price change

24h

Current

Min

0.93

Max

1.07

Key metrics
By Trading Economics
Income	33M 28M
Sales	35M 35M
EPS	0.89
Profit margin	79.717
Employees	25
EBITDA	33M 28M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+236.54% upside

Dividends
By Acuity
Next Earnings	12 Nov 2026

Market Stats
By TradingEconomics
Market Cap	-1.3M 24M
Previous open	-7.39
Previous close	1.03

Actinium Pharmaceuticals Inc Chart

Past performance is not a reliable indicator of future results.

Related News

14 Aug 2026, 23:56 UTC

Columbia Banking System Inc shares are higher in after-market trading, maintaining an upward trend since Friday's close, with no specific news identified for the movement.

14 Aug 2026, 23:56 UTC

Lowe's Companies Inc saw modest gains during after-market hours, trading near the upper end of its one-month range and above its 20-day moving average.

14 Aug 2026, 23:56 UTC

CEVA Inc shares are higher in after-market trading, reaching a session high earlier. The stock remains within its one-month trading range.

14 Aug 2026, 23:56 UTC

Whirlpool Corp shares are trading lower in after-market hours. No specific news was identified to explain the movement.

14 Aug 2026, 23:56 UTC

ETF Constituents

Vanguard FTSE Developed Markets ETF rises in after-market trading, supported by strong performances from top holdings including UL, KB, SAP, FLUT, and CVE.

14 Aug 2026, 23:56 UTC

Ardelyx Inc. shares declined in after-market trading, continuing a broader trend of significant decline over the past month, remaining below the 20-day moving average.

14 Aug 2026, 23:56 UTC

Aptiv PLC shares are trading higher in after-market hours following an early spike, amid a market characterized by complacency and stable equities.

14 Aug 2026, 23:56 UTC

Fox Corp shares are lower in after-market hours, showing unusual volatility. No specific news was identified to explain the movement.

14 Aug 2026, 23:56 UTC

Encore Capital Group Inc shares are higher in after-market trading, continuing a positive trend following four consecutive sessions of gains. No specific news was identified.

14 Aug 2026, 23:56 UTC

Commercial Metals Co. shares declined after-market, continuing a trend of three consecutive lower daily closes, despite remaining above the 20-day moving average.

14 Aug 2026, 23:56 UTC

ETF Constituents

The Consumer Staples Select Sector SPDR Fund is trading higher in after-market hours, supported by gains from top holdings like Monster Beverage and Walmart.

14 Aug 2026, 23:56 UTC

Macro News

ETF Constituents

VanEck Gold Miners ETF rises in after-market trading amid U.S.-Iran tensions and a weaker U.S. Dollar Index, boosting demand for safe-haven assets.

14 Aug 2026, 23:56 UTC

Cognizant Technology Solutions shares are higher in after-market trading, recovering from earlier losses amid a mixed backdrop in global equity markets.

14 Aug 2026, 23:52 UTC

News

Boeing Co secures over $711 million in U.S. defense contract modifications, boosting investor sentiment. Shares are higher in after-market trading.

14 Aug 2026, 23:51 UTC

Insight Enterprises Inc. shares are trading slightly lower after-market, amid broader market concerns following a surprising decline in U.S. retail sales for July.

14 Aug 2026, 23:51 UTC

Turning Point Brands Inc shares are higher in after-market hours, trading above their 20-day moving average amid broader market concerns over declining U.S. retail sales.

14 Aug 2026, 23:51 UTC

ETF Constituents

Energy Select Sector SPDR Fund rose in after-market hours, driven by gains from Valero Energy, Chevron, and Exxon Mobil, offsetting minor declines from Marathon and Occidental.

14 Aug 2026, 23:51 UTC

Vipshop Holdings Ltd shares are higher in after-market hours, diverging from recent declines despite a drop in U.S. retail sales for July.

14 Aug 2026, 23:51 UTC

Kanzhun Ltd. shares are lower in after-market hours, reflecting a decline following disappointing U.S. retail sales data and shifting market sentiment on interest rates.

14 Aug 2026, 23:51 UTC

Cognex Corp shares are lower in after-market hours amid broader market concerns following a decline in U.S. retail sales for July.

14 Aug 2026, 23:51 UTC

Abercrombie & Fitch Co shares are lower in after-market hours following a decline in U.S. retail sales for July, raising concerns about consumer spending.

14 Aug 2026, 23:51 UTC

RingCentral Inc. shares are higher in after-market trading, reflecting positive momentum following Friday's close, despite concerns over July's U.S. retail sales decline.

14 Aug 2026, 23:51 UTC

Social Media

Moderna shares are lower in after-market hours amid concerns over the FDA's approval of its mRNA flu vaccine and modest trial data effectiveness.

14 Aug 2026, 23:51 UTC

Tower Semiconductor shares are higher in after-market trading, remaining above their 20-day moving average despite a decline in U.S. retail sales for July.

14 Aug 2026, 23:51 UTC

Karyopharm Therapeutics shares are higher in after-market trading, despite no specific news. Broader market sentiment reflects concerns from a decline in U.S. retail sales.

14 Aug 2026, 23:51 UTC

News

PayPal is in advanced talks for a potential sale to Stripe and Advent, following a proposal of $60.50 per share. Shares are higher in after-market trading.

14 Aug 2026, 23:51 UTC

China's House Price Index YoY release on August 17, 2026, signals cautious market sentiment amid ongoing housing challenges and weak demand.

14 Aug 2026, 23:51 UTC

Social Media

BJ's Wholesale Club Holdings Inc. is trading higher in after-market hours following its scheduled earnings report amid positive market sentiment despite a drop in U.S. retail sales.

14 Aug 2026, 23:51 UTC

Griffon Corp shares are lower in after-market hours amid weak market sentiment and disappointing U.S. retail sales data, which diverged from expectations.

14 Aug 2026, 23:51 UTC

In after-market trading, Bloomin' Brands Inc is moving higher, reflecting strong performance despite a decline in U.S. retail sales for July.

Peer Comparison

Price change

Actinium Pharmaceuticals Inc Forecast

Price Target

By TipRanks

236.54% upside

12 Months Forecast

Average 3.5 USD 236.54%

High 4 USD

Low 3 USD

Based on 2 Wall Street analysts offering 12 month price targets forActinium Pharmaceuticals Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

Buy

Hold

Sell

Based on 2 analysts giving stock ratings to Actinium Pharmaceuticals Inc - Dist in the past 3 months.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Actinium Pharmaceuticals Inc

Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies. Its Iomab-B is an induction and conditioning agent prior to bone marrow transplant in patients with relapsed and refractory acute myeloid leukemia (r/r AML). The company focuses on advancing its development for product candidate Actimab-A, a therapeutic agent that has demonstrated potential activity in r/r AML patients. In addition, it engages with the National Cancer Institute under the cooperative research and development agreement for the development of Actimab-A in AML and other myeloid malignancies. Its Iomab-ACT, a next generation conditioning candidate, is being developed for improving patient access and outcomes for curative cell and gene therapies. Further, the company's research and development activities primarily focus on advancing various preclinical programs for solid tumor indications. The company holds approximately 235 patents and patent applications, including various patents related to the manufacture of the isotope Ac-225 in a cyclotron. The company is based in New York, New York.